ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
83,015
-0,13%
Bitcoin
63 818,14
-0,28%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Karyopharm Therapeutics Inc (KPTI)

  7. Karyopharm Therapeutics Inc (KPTI) Actualités

KPTI Karyopharm Therapeutics Inc

1,11
0,02 (1,83%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Karyopharm Therapeutics Inc KPTI NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,02 1,83% 1,11 06:00:14
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,11 1,08 1,185 1,13 1,09
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202422:30PRNUSKaryopharm to Report First Quarter 2024 Financial Results on..
01/5/202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
24/4/202422:01PRNUSKaryopharm Announces Presentations in Endometrial Cancer and..
01/4/202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
06/3/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:05PRNUSKaryopharm to Participate at Barclays 26th Annual Global..
05/3/202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
29/2/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202413:43EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202413:35EDGAR2Form 8-K - Current report
29/2/202413:30PRNUSKaryopharm Reports Fourth Quarter and Full Year 2023..
22/2/202413:00PRNUSKaryopharm to Report Fourth Quarter and Full Year 2023..
20/2/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202414:00EDGAR2Form 8-K - Current report
14/2/202416:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202412:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
26/1/202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202401:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202400:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202400:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:40EDGAR2Form 8-K - Current report
08/1/202414:30PRNUSKaryopharm Announces Preliminary Unaudited 2023 Revenue and..
03/1/202413:00PRNUSKaryopharm to Present at 42nd Annual J.P. Morgan Healthcare..
02/1/202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
12/12/202322:05EDGAR2Form 8-K - Current report
11/12/202302:15PRNUSKaryopharm Shares Data at ASH 2023 Showing Strong SVR and..
05/12/202323:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
08/11/202322:05PRNUSKaryopharm to Participate at Upcoming Investor Conferences
07/11/202323:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202313:00PRNUSKaryopharm Announces New Preliminary Data in Overall..
02/11/202314:20PRNUSKaryopharm Announces Presentations at the 65th American..
02/11/202312:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Dernières Valeurs Consultées

NASDAQ
KPTI
Karyopharm Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés